Home Newsfeeds HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Celularity (NASDAQ:CELU) with a Buy and lowers the price target from $15 to $2.5.

byBenzinga Newsdesk

January 30, 2023

1 minute read

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Celularity (NASDAQ:CELU) with a Buy and lowers the price target from $15 to $2.5.

Raymond James Maintains Outperform on Coterra Energy, Lowers Price Target to $36

By Benzinga Newsdesk

October 24, 7:51 AM

Raymond James analyst John Freeman maintains Coterra Energy (NYSE:CTRA) with a Outperform and lowers the price target from $42 to $36.

CTRA

Why Agriculture & Construction Equipment Maker CNH Industrial’s Shares Are Diving Today

By Lekha Gupta

November 7, 1:27 PM

CNH Industrial NV (NYSE: CNHI) shares are trading lower by around 9% after it reported

CNHI

Why This Etsy Analyst Expects Q4 Earnings Beat This Week

By Wayne Duggan

February 20, 3:16 PM

Etsy Inc (NASDAQ: ETSY) is off to a strong start to 2023, and one analyst said investors can expect some positive fourth-quarter numbers from the company on Wednesday.

ETSY

Analyst Says Bitcoin Surge Has Just Begun, Anticipates This Price Target By February

By Bibhu Pattnaik

January 21, 2:29 PM

Bitcoin (CRYPTO: BTC) is soaring on Saturday, surpassing $23,000 for the first time since mid-August 2022.

BTC

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

Related Posts

Raymond James Maintains Outperform on Coterra Energy, Lowers Price Target to $36

Why Agriculture & Construction Equipment Maker CNH Industrial’s Shares Are Diving Today

Why This Etsy Analyst Expects Q4 Earnings Beat This Week

Analyst Says Bitcoin Surge Has Just Begun, Anticipates This Price Target By February